{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:34:01Z","timestamp":1761356041971,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.arcped.2025.08.004","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T04:58:23Z","timestamp":1759813103000},"page":"475-478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary leukotriene E4 in pediatric pulmonary arterial hypertension: a pilot case control study"],"prefix":"10.1016","volume":"32","author":[{"given":"Hamdy","family":"El-Sayed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Elmarsafawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basma","family":"Shouman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0819-3228","authenticated-orcid":false,"given":"Amal","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2025.08.004_bib0001","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01916-2018","article-title":"Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management","volume":"53","author":"Rosenzweig","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arcped.2025.08.004_bib0002","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.arcped.2025.08.004_bib0003","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019882635","article-title":"A new treatment for severe pulmonary arterial hypertension based on an old idea: inhibition of 5-lipoxygenase","volume":"10","author":"Voelkel","year":"2020","journal-title":"Pulm Circ"},{"key":"10.1016\/j.arcped.2025.08.004_bib0004","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/0194599819871700","article-title":"Establishing urinary leukotriene E4 as a diagnostic biomarker for chronic rhinosinusitis with comorbid asthma and atopy","volume":"161","author":"Santarelli","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.arcped.2025.08.004_bib0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12026-014-8492-5","article-title":"Leukotrienes in pulmonary arterial hypertension","volume":"58","author":"Tian","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.arcped.2025.08.004_bib0006","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.pcl.2020.06.005","article-title":"Pediatric pulmonary arterial hypertension","volume":"67","author":"Frank","year":"2020","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.arcped.2025.08.004_bib0007","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/j.2040-4603.2021.tb00176.x","article-title":"Pediatric Pulmonary hypertension: definitions, mechanisms","volume":"11","author":"Mukherjee","year":"2021","journal-title":"Diagn Treat Compr Physiol"},{"key":"10.1016\/j.arcped.2025.08.004_bib0008","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/rccm.202110-2428OC","article-title":"Twenty-year experience and outcomes in a national pediatric Pulmonary hypertension service","volume":"206","author":"Constantine","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arcped.2025.08.004_bib0009","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/jcm9061717","article-title":"Children and adolescents with pulmonary arterial hypertension: baseline and follow-up data from the polish registry of pulmonary hypertension (BNP-PL)","volume":"9","author":"Kwiatkowska","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.arcped.2025.08.004_bib0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/687764","article-title":"Clinical classification in pediatric pulmonary arterial hypertension associated with congenital heart disease","volume":"6","author":"Zijlstra","year":"2016","journal-title":"Pulm Circ"},{"key":"10.1016\/j.arcped.2025.08.004_bib0011","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.chest.2022.11.038","article-title":"Characteristics, long-term survival, and risk assessment of pediatric pulmonary arterial hypertension in China: insights from a National multicenter prospective registry","volume":"163","author":"Qian","year":"2023","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.arcped.2025.08.004_bib0012","first-page":"459","article-title":"Effects of leukotriene receptor antagonist on chronic obstructive [correction of obstractive] pulmonary disease induced pulmonary hypertension","volume":"116","author":"Bu","year":"2003","journal-title":"Chin Med J"},{"key":"10.1016\/j.arcped.2025.08.004_bib0013","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1017\/S1047951124000362","article-title":"Leukotriene B4 levels in CHD-associated paediatric pulmonary hypertension","volume":"34","author":"Vuran","year":"2024","journal-title":"Cardiol Young"},{"key":"10.1016\/j.arcped.2025.08.004_bib0014","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-1-4615-4793-8_45","article-title":"LTE4 blood levels in infants with congenital heart lesions","volume":"469","author":"Gascard","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.arcped.2025.08.004_bib0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/09629359791451","article-title":"Pulmonary hypertension in infants with congenital heart defects: are leukotrienes involved?","volume":"6","author":"Serraf","year":"1997","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.arcped.2025.08.004_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115216","article-title":"Urinary LTE4 levels as a diagnostic marker for IgE-mediated asthma in preschool children: a birth cohort study","volume":"9","author":"Chiu","year":"2014","journal-title":"PLoS One"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X25001794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X25001794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:28:36Z","timestamp":1761355716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X25001794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0929693X25001794"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2025.08.004","relation":{},"ISSN":["0929-693X"],"issn-type":[{"type":"print","value":"0929-693X"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary leukotriene E4 in pediatric pulmonary arterial hypertension: a pilot case control study","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2025.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de p\u00e9diatrie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}